Minima Growth Stent
Commercial- Indications
- Aortic stenosis, Pulmonary artery stenosis
Company intelligence / Profile preview
Renata Medical has developed and commercialized the Minima Stent system, which is FDA approved for treating infant vascular stenosis. The stent is designed to be implanted in small infants and can be gradually expanded as the child grows, potentially reducing or eliminating the need for multiple surgeries over a patient’s lifetime. Early clinical adoption includes successful first-in-region implants and positive impact on pediatric CHD care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renata Medical.